spectinomycin has been researched along with isoniazid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Andersen, RJ; Centko, RM; Miao, VP; Patrick, BO; Ramón-García, S; Taylor, T; Thompson, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baskakova, SA; Charushin, VN; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Kravchenko, MA; Kungurov, NV; Pervova, MG; Rusinov, GL; Skornyakov, SN; Verbitskiy, EV; Zil'berberg, NV | 1 |
Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
Bach, VT; Thadepalli, H | 1 |
1 review(s) available for spectinomycin and isoniazid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for spectinomycin and isoniazid
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Ramariolides A-D, antimycobacterial butenolides isolated from the mushroom Ramaria cystidiophora.
Topics: 4-Butyrolactone; Acinetobacter; Agaricales; Animals; Anti-Bacterial Agents; Antitubercular Agents; Escherichia coli; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Pseudomonas aeruginosa; Salmonella typhimurium | 2012 |
Synthesis and biological evaluation of novel 5-aryl-4-(5-nitrofuran-2-yl)-pyrimidines as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Nitro Compounds; Pyrimidines; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |
Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; beta-Lactamases; Cephalosporins; Chloramphenicol; Clindamycin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Penicillins; Rifampin; Spectinomycin; Tetracyclines | 1980 |